The cellular and extracellular proteomic signature of human dopaminergic neurons carrying the LRRK2 G2019S mutation
BackgroundExtracellular vesicles are easily accessible in various biofluids and allow the assessment of disease-related changes in the proteome. This has made them a promising target for biomarker studies, especially in the field of neurodegeneration where access to diseased tissue is very limited....
Saved in:
| Main Authors: | Felix Knab, Giambattista Guaitoli, Mohamed Ali Jarboui, Felix von Zweydorf, Fatma Busra Isik, Franziska Klose, Anto Praveen Rajkumar, Thomas Gasser, Christian Johannes Gloeckner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1502246/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism
by: Bernd K Gilsbach, et al.
Published: (2024-12-01) -
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
by: Daniela Mercatelli, et al.
Published: (2025-05-01) -
Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson’s disease
by: Hsin Fen Chien, et al.
Published: (2014-05-01) -
LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosome
by: Michael T. Maloney, et al.
Published: (2025-08-01) -
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils
by: Alice Filippini, et al.
Published: (2025-05-01)